The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Distinct patterns of somatic mutation clearance and association with clinical outcome in patients with AML.
 
Koichi Takahashi
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose
 
Keyur Patel
No Relationships to Disclose
 
Carlos E. Bueso-Ramos
No Relationships to Disclose
 
Ghayas C. Issa
No Relationships to Disclose
 
Xingzhi Song
No Relationships to Disclose
 
Jianhua Zhang
No Relationships to Disclose
 
Samantha Tippen
No Relationships to Disclose
 
Latasha Little
No Relationships to Disclose
 
Curtis Gumbs
No Relationships to Disclose
 
Farhad Ravandi
No Relationships to Disclose
 
Tapan M. Kadia
No Relationships to Disclose
 
Naval Guastad Daver
No Relationships to Disclose
 
Courtney Denton Dinardo
Honoraria - Agios; Daiichi Sankyo; Novartis
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo; Novartis
 
Marina Konopleva
Stock and Other Ownership Interests - Reata Pharmaceuticals
Honoraria - Abbvie; Calithera Biosciences; Genentech
Consulting or Advisory Role - AbbVie
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Cellectis (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); Stemline Therapeutics (Inst)
 
Michael Andreeff
No Relationships to Disclose
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; ARIAD; BiolineRx; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Immunogen (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Teva (Inst)
 
Elias Jabbour
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
 
Andrew Futreal
No Relationships to Disclose
 
Hagop M. Kantarjian
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)